John Reddy - Octave Specialty Independent Director

OSG Stock  USD 5.86  0.08  1.38%   

Director

Mr. John Patrick Reddy is Independent Director of the company. Mr. Reddy is currently a business consultant and private investor. From 2009 until March 2017, he served as the Chief Financial Officer of Spectra Energy Corporationrationration, a premier owner and operator of pipeline and midstream energy assets. Prior to that, he served as Senior Vice President and Chief Financial Officer of Atmos Energy Corporationrationration, the nations largest natural gasonly distributor, and in various financial roles with Pacific Enterprises Corporationrationration. He currently serves on the audit committee and the conflicts committee of Hess Midstream Partners and chairs the audit committee of PLH Group. Mr. Reddy has also served on the board of directors of DCP Midstream, LLC and as a member of Paragon Offshore Plcs board from July 2014 through June 2017 since 2018.
Age 67
Tenure 8 years
Professional MarksMBA
Address 40 Wall Street, New York, NY, United States, 10005
Phone212 658 7470
Webhttps://www.octavegroup.com
Reddy is a graduate of the University of California at Los Angeles and holds an MBA from the University of Southern California.

Octave Specialty Management Efficiency

The Octave Specialty's current Return On Tangible Assets is estimated to increase to -0.08. The Octave Specialty's current Return On Capital Employed is estimated to increase to -0.0083. At this time, Octave Specialty's Other Assets are most likely to increase significantly in the upcoming years. The Octave Specialty's current Intangible Assets is estimated to increase to about 551.6 M, while Non Currrent Assets Other are projected to decrease to roughly 6.9 B. Octave Specialty's management efficiency ratios could be used to measure how well Octave Specialty manages its routine affairs as well as how well it operates its assets and liabilities.
Octave Specialty Group has 150 M in debt with debt to equity (D/E) ratio of 1.71, which is OK given its current industry classification. Octave Specialty has a current ratio of 0.74, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. That said, strategic use of leverage may enable Octave to fund expansion initiatives and generate superior returns.

Similar Executives

Showing other executives

DIRECTOR Age

Debbie NalchajianCohenCommunity West Bancshares
N/A
Theodore ShastaMBIA Inc
70
Steven FreibergRegional Management Corp
63
James WehrGlobal Indemnity Group
62
Jason HurwitzGlobal Indemnity Group
47
Sandra JohnsonRegional Management Corp
59
Roel CamposRegional Management Corp
71
Maria ContrerasSweetRegional Management Corp
65
Susan TimanGreene County Bancorp
N/A
Bruce LedermanGlobal Indemnity Group
77
Joseph BrownGlobal Indemnity Group
77
Richard VaughanMBIA Inc
71
Steven GilbertMBIA Inc
74
Steven McDonaldCommunity West Bancshares
76
John IllgenCommunity West Bancshares
79
Michael DunnRegional Management Corp
68
Jonathan BrownRegional Management Corp
35
Seth GerschGlobal Indemnity Group
72
Diane DewbreyMBIA Inc
56
Robert JanneyBlue Ridge Bankshares
76
Overseas Shipholding Group, Inc., together with its subsidiaries, owns and operates a fleet of oceangoing vessels. The company was founded in 1948 and is headquartered in Tampa, Florida. Overseas Shipholding operates under Oil Gas Midstream classification in the United States and is traded on New York Stock Exchange. It employs 953 people. Octave Specialty Group (OSG) is traded on New York Stock Exchange in USA and employs 380 people. Octave Specialty Group was previously known as Ambac Financial Group and was traded on New York Stock Exchange under the symbol AMBC. Octave Specialty is listed under Insurance Brokers category by Fama And French industry classification.

Management Performance

Octave Specialty Leadership Team

Elected by the shareholders, the Octave Specialty's board of directors comprises two types of representatives: Octave Specialty inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Octave. The board's role is to monitor Octave Specialty's management team and ensure that shareholders' interests are well served. Octave Specialty's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Octave Specialty's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lawrence Metz, Senior Counsel
Anja Manuel, Independent Director
Kate Smith, Director Communications
Richard CPA, VP CFO
John Reddy, Independent Director
Cristina Ahn, Chief Officer
Rebecca DeLaet, Independent Director
Gary Taylor, Independent Director
Randy Paez, Chief Officer
Rhonta Smith, Executive Director
Karen Beyer, MD Relations
William White, Assistant VP
Cheryl Walter, Chief Officer
Joseph Kronsberg, Independent Director
Richard Trueblood, Chief Financial Officer, Vice President
Patrick OHalloran, Chief Operations Officer, Vice President
Ty Wallach, Independent Director
CPA CPA, VP CFO
Damon Mote, Vice President and Chief Administrative Officer
Julie Silcock, Independent Director
Samuel Norton, President, Chief Executive Officer, Director
Douglas Wheat, Independent Non-Executive Chairman of the Board
Claude CPA, CEO President
Susan Allan, Vice President General Counsel and Corporate Secretary
Daniel CPCU, Senior Director
Naveen Anand, President Group
David Trick, CFO VP
Steven Dresner, President Group
Stephen Ksenak, Chief Officer

Octave Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Octave Specialty a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Octave Specialty is a strong investment it is important to analyze Octave Specialty's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Octave Specialty's future performance. For an informed investment choice regarding Octave Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Octave Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Can Insurance Brokers industry sustain growth momentum? Does Octave have expansion opportunities? Factors like these will boost the valuation of Octave Specialty. Anticipated expansion of Octave directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Octave Specialty demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(0.98)
Revenue Per Share
5.309
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.01)
Return On Equity
(0.06)
Investors evaluate Octave Specialty using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Octave Specialty's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Octave Specialty's market price to deviate significantly from intrinsic value.
It's important to distinguish between Octave Specialty's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Octave Specialty should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Octave Specialty's market price signifies the transaction level at which participants voluntarily complete trades.